Back

Frailty status, aging, and mortality risk in heart failure

29 August 2025 (13:15 - 13:25)
Organised by: Logo
Congress Presentation Part of: Comorbidities and heart failure therapies Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Caroline Hartwell Garred

Herlev Hospital, Herlev (Denmark)

5 More presentations in this session

Presentation thumbnail
The impact of malnutrition severity on mortality risk in super-elderly patients with acute heart failure: a Geriatric Nutritional Risk Index-based assessment
Doctor T. Murakami (Kawagoe, JP)
Abstract Slides Video
Presentation thumbnail
Incidence and outcomes of dementia after a diagnosis of heart failure: a population-based study
Mr P. Tieu (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Newer GLP-1 receptor agonists and clinical outcomes in heart failure with reduced ejection fraction: a real-world comparative study
Associate Professor A. Kalogeropoulos (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
Heart failure treatment optimization in patients with dystrophin-related muscular dystrophy and HFrEF
Doctor L. Monzo (Vandoeuvre-Les-Nancy, FR)
Abstract Slides Video
Presentation thumbnail
Comorbidity burden in patients with cardiogenic shock: a cardiogenic shock working group analysis
Doctor J. Sundermeyer (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Comorbidities and heart failure therapies
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Session
The pandemic of ageing in heart failure: age, frailty, and cognition
thumbnail
Congress Presentation
Temporal trends in mortality and hospitalisation risk in patients with heart failure according to frailty status
thumbnail
Congress Presentation
Changes in frailty status over time and its impact on clinical outcomes after diagnosis of heart failure in primary care: population-based observational study in the UK

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources